Asthma trials recruiting in Pennsylvania

All Asthma trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
  NCT07532265 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Pennsylvania: Horsham, Philadelphia, Pittsburgh
• A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
  NCT07556159 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh
• A Study of CDX-622 in Participants With Mild to Moderate Asthma
  NCT07330778 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh
• A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
  NCT07456033 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Pennsylvania: DuBois, Wyomissing
• A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
  NCT07323654 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
  NCT07219173 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
  NCT06977581 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Pennsylvania: DuBois
• Acoustic Waveform Respiratory Evaluation
  NCT06512064 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 70 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Bilevel Positive Airway Pressure (BPAP) for Severe Asthma
  NCT07582211 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
  NCT06979323 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: DuBois, Philadelphia
• Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
  NCT06932263 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: DuBois, Philadelphia, Smithfield
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
  NCT04743791 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Pennsylvania: Hershey
• Pollution Intervention to Impact Kids Asthma Study
  NCT07261423 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
  NCT06750289 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · Pennsylvania: DuBois
• SMART Implementation-Effectiveness Trial 1
  NCT07137923 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 18 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• SMART Implementation-Effectiveness Trial 2
  NCT07138027 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 18 Years · Sex: All (male and female) · Pennsylvania: Philadelphia